Treatment of community-acquired pneumonia during the coronavirus disease 2019 (COVID-19) pandemic
This short review from the US perspective describes an interpretation of ISDA guidance for CAP in the context of the COVID pandemic. It suggests that as far as is currently known, bacterial pathogens in COVID-19 plus CAP are likely to be the same as CAP alone.
Source:
Annals of Internal Medicine
Resource links:
NICE CG173 (COVID-19 rapid guideline: antibiotics for pneumonia in adults in hospital):
SPS commentary:
NICE has produced rapid guidance on antibiotics for pneumonia in adults in hospital, and managing suspected or confirmed pneumonia in adults in the community in the context of the COVID-19 pandemic.